Publications
Targeted Tissue Delivery of RNA Therapeutics Using Antibody–Oligonucleotide Conjugates (AOCs)
Nucleic Acids Research
Barbora Malecova, Rob S Burke, Michael Cochran, Michael D Hood, Rachel Johns, Philip R Kovach, Venkata R Doppalapudi, Gulin Erdogan, J Danny Arias, Beatrice Darimont, Christopher D Miller, Hanhua Huang, Andrew Geall, Husam S Younis, Arthur A Levin. Nucleic Acids Research, 2023;, gkad415, https://doi.org/10.1093/nar/gkad415
Targeting Therapeutic Oligonucleotides
The New England Journal of Medicine
Levin, AA. N Engl J Med 2017;376:1DOI 10.1056/NEJMcibr1613559
Treating Disease at the RNA Level with Oligonucleotides
The New England Journal of Medicine
Levin, AA. N Engl J Med 2019;380:1DOI: 10.1056/NEJMra1705346
Presentations
2023 75th AAN Annual Meeting
2023 MDA Clinical and Scientific Conference
AOC 1020: An Antibody Oligonucleotide Conjugate (AOC) in Development for the Treatment of FSHD
2022 World Muscle Society Congress
AOC 1020: An Antibody Oligonucleotide Conjugate (AOC) in Development for the Treatment of FSHD
2022 FSHD Society International Research Congress
AOC 1020: An Antibody Oligonucleotide Conjugate (AOC) in Development for the Treatment of FSHD
2022 74th AAN Annual Meeting
2022 MDA Clinical and Scientific Conference
2021 MDA Virtual Clinical and Scientific Conference
DUX4 siRNA Optimization for the Development of an Antibody-Oligonucleotide Conjugate (AOC™) for the Treatment of FSHD
2021 AAN Annual Meeting
Optimization of AOC 1001, an antibody-oligonucleotide conjugate targeting the underlying cause of myotonic dystrophy type 1
2021 FSHD Society IRC Annual Meeting
DUX4 siRNA Optimization for the Development of an Antibody Oligonucleotide Conjugate (AOC™) for the Treatment of FSHD